Organization · Venture Capital
Tiventures SA
TiVentures SA is a seed investment fund based in southern Switzerland, focusing on early-stage companies in the life sciences, medical, high-tech, and IT sectors. It aims to foster innovation and economic growth in the Ticino region.
Overview
What Tiventures SA does
What Tiventures SA is
TiVentures SA is a seed investment fund based in southern Switzerland, focusing on early-stage companies in the life sciences, medical, high-tech, and IT sectors. It aims to foster innovation and economic growth in the Ticino region.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Tiventures SA elsewhere
Open the official website or a supported primary organization account.
Capability profile
Tiventures SA as a funder
Investment thesis
Ti-Ventures SA invests exclusively in early-stage companies based in Ticino, Switzerland, focusing on innovative technologies with high growth potential. The fund aims to foster economic diversification and innovation growth in the region by collaborating with local universities and government.
Focus narrative
Ti-Ventures invests in early-stage companies located in Ticino, Switzerland. The fund emphasizes sectors such as life sciences, medical technology, high-tech, and information technology. It collaborates with local universities, the state government, and other stakeholders to foster economic growth and innovation in the region.
Value beyond capital
Ti-Ventures adds value to its portfolio companies by leveraging deep integration with the local innovation ecosystem, collaborating with Agire (the cantonal innovation agency), the Ticino State Government, and local universities. The management team consists of hands-on entrepreneurs with international VC experience in biomedical and high-tech areas, providing strategic guidance and support.
Focus and fit
- Stages
- Seed
- Regions
- EuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Gain Therapeutics and Sailogy
Portfolio context
Ti-Ventures has a diversified portfolio that includes notable companies such as: Gain Therapeutics: Involved in drug development, it went public on NASDAQ in 2021. Sailogy: A company that successfully exited in 2018. Delvitech SA: Received seed investment in 2018 and participated in a Series A round in 2020. xFarm: Engaged in agricultural technology, it has undergone multiple funding rounds, including a Series B round in 2022 and a Series C round planned for 2024. BigOmics Analytics: Received seed investment in 2021 and participated in a Series A round in 2022.
Common questions
What to know about Tiventures SA
Upseed classifies Tiventures SA under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.